{“title”:”India Must Resist EU, US Pressure on Data Exclusivity in Farm-Chemicals to Preserve Its Right to Innovation, Experts Warn”,”content”:”

India is being urged by the European Union and the United States to accept “data exclusivity” provisions in its ongoing free trade agreements, which could severely compromise the country’s ability to innovate and produce affordable farm-chemicals. The data exclusivity clause, a contentious provision that has been a point of contention in international trade agreements, would bar generic manufacturers in India from accessing critical data on the safety and efficacy of existing drugs and pesticides for a set period of time, typically five to 10 years. This, experts warn, would undermine India’s domestic R&D capabilities, increase the financial burden on farmers and consumers, and hinder the country’s efforts to achieve its ambitious goal of doubling farm income by 2025.

First Section

The Global Trade Research Initiative (GTRI), a think-tank that has been at the forefront of analyzing the implications of international trade agreements on India’s economy, has issued a stern warning against accepting data exclusivity provisions in its free trade agreements. The organization’s research has shown that data exclusivity would lead to a surge in prices of farm-chemicals, making it increasingly difficult for farmers to access affordable inputs. This, in turn, would compromise India’s food security and threaten the livelihoods of millions of farmers who depend on the sector for their income.

The GTRI’s warning comes at a time when India is in the midst of negotiating free trade agreements with several countries, including the European Union and the United States. While these agreements hold the promise of increased trade and investment, they also pose significant risks to India’s economic sovereignty and its ability to regulate its domestic market. The data exclusivity provision, in particular, has been a contentious issue in international trade negotiations, with many countries, including India, resisting its inclusion in trade agreements.

Second Section

Experts argue that data exclusivity would stifle innovation in India’s pharmaceutical and agrochemical sectors, which have been at the forefront of the country’s innovation drive in recent years. The clause would prevent generic manufacturers from accessing critical data on the safety and efficacy of existing drugs and pesticides, forcing them to conduct costly and time-consuming clinical trials to prove the efficacy of generic versions. This, they warn, would lead to a surge in prices of farm-chemicals, making it increasingly difficult for farmers to access affordable inputs.

The GTRI’s research has also shown that data exclusivity would have a disproportionate impact on small and medium-sized enterprises (SMEs) in India’s agrochemical sector, which are already struggling to stay afloat in the face of intense competition from multinational corporations. By preventing SMEs from accessing critical data, data exclusivity would further concentrate the market, leading to a loss of diversity and innovation in the sector.

Third Section

India’s resistance to data exclusivity provisions in its free trade agreements is seen as a crucial test of its ability to protect its economic sovereignty and promote its domestic innovation capabilities. While the EU and the US have been pushing hard for the inclusion of data exclusivity provisions in their trade agreements with India, New Delhi has been steadfast in its opposition, citing concerns over the impact on its domestic R&D capabilities and food security.

The GTRI’s warning to India to resist EU and US pressure on data exclusivity provisions is a timely reminder of the need for the country to prioritize its domestic interests in international trade negotiations. By standing firm against data exclusivity, India can preserve its right to innovation, promote its domestic R&D capabilities, and ensure that its farmers have access to affordable inputs. The stakes are high, but India’s policymakers must demonstrate the courage to resist external pressure and prioritize the country’s economic sovereignty and food security.

“,”excerpt”:”India is being urged to accept data exclusivity provisions in its free trade agreements, which could compromise its ability to innovate and produce affordable farm-chemicals.”,”tags”:[“India”,”EU”,”US”,”free trade agreements”,”data exclusivity”,”farm-chemicals”,”GTRI”],”meta_description”:”India must resist EU, US pressure on data exclusivity in farm-chemicals to preserve its right to innovation, experts warn.”}